Clinical characteristic | n=1405* |
AIP mutation, n (%) | 134 (9.5) |
Familial, n (%) | 607 (43.2) |
Gender, n (% male) | 680 (48.5) |
Diagnosis, n (%) | |
GH excess | 767 (55.5) |
NFPA | 185 (13.4) |
Prolactinoma | 344 (24.9) |
Cushing’s disease | 74 (5.4) |
Other diagnosis | 11 (0.8) |
Age of onset (years) | 27.1±13.1 |
Age at diagnosis (years) | 30.8±13.4 |
Macroadenoma, n (%) | 977 (81.5) |
Extrasellar extension, n (%) | 446 (60.1) |
Pituitary apoplexy, n (%) | 48 (3.9) |
↵*Prospectively diagnosed patients excluded.
NFPA, non-functioning pituitary adenoma.